Global Markets for Therapeutic Botulinum Toxin 2009

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL THERAPEUTIC BOTULINUM TOXIN MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Product Background
  • 1.2.2 Procedure Overview
  • 1.2.2.1 US Procedures
  • Cervical Dystonia Procedures
  • Blepharospasm Procedures
  • Strabismus Procedures
  • Severe Primary Axillary Hyperhidrosis
  • 1.2.2.2 European Procedures
  • 1.2.2.3 Japanese Procedures
  • 1.2.2.4 Emerging Procedures
  • 1.2.3 Market Forecast
  • 1.2.3.1 US Therapeutic Botulinum Toxin Market
  • 1.2.3.2 European Therapeutic Botulinum Toxin Market
  • 1.2.3.3 Japanese Therapeutic Botulinum Toxin Market
  • 1.2.4 Market Drivers and Limiters
  • 1.2.4.1 Market Drivers
  • 1.2.4.2 Market Limiters
• 1.3 Competitive Analysis
  • 1.3.1 Leading Competitors
  • 1.3.2 Emerging Competitors

2.0 US THERAPEUTIC BOTULINUM TOXIN MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Market Forecast
  • 2.2.2 Market Drivers and Limiters
  • 2.2.2.1 Market Drivers
  • 2.2.2.2 Market Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Leading Competitors
  • 2.3.2 Emerging Competitors

3.0 EUROPEAN THERAPEUTIC BOTULINUM TOXIN MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Market Forecast
  • 3.2.2 Market Drivers and Limiters
  • 3.2.2.1 Market Drivers
  • 3.2.2.2 Market Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Leading Competitors
  • 3.3.2 Emerging Competitors

4.0 JAPANESE THERAPEUTIC BOTULINUM TOXIN MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Market Forecast
  • 4.2.2 Market Drivers and Limiters
  • 4.2.2.1 Market Drivers
  • 4.2.2.2 Market Limiters
• 4.3 Competitive Analysis
  • 4.3.1 Leading Competitors
  • 4.3.2 Emerging Competitors

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

• EXECUTIVE SUMMARY
• Exhibit 1: Therapeutic BTX Market, Global (US$), 2007 - 2013
• Exhibit 2: Therapeutic BTX Market, by Indication, US, as a % of Total, 2008 and 2013
• Exhibit 3: Therapeutic BTX Market Units, Europe, 2007 - 2013
• Exhibit 4: Therapeutic BTX Market, Japan (US$), 2007 - 2013
• Exhibit 5: Leading Competitors in the Therapeutic BTX Market, Global, 2008

METHODOLOGY

• Exhibit 6: Currency Exchange Rates, 2008

CHAPTER 1: GLOBAL THERAPEUTIC BOTULINUM TOXIN MARKET

• Exhibit 7: Therapeutic BTX Market, by Country, Global (US$), 2007 - 2013 (Graphical Format)
• Exhibit 8: Therapeutic BTX Product Overview, Global, 2008
• Exhibit 9: Therapeutic BTX Procedures, by Country, Global, 2007 - 2013
• Exhibit 10: Therapeutic BTX Procedures, by Procedure Type, US, 2007 - 2013
• Exhibit 11: Therapeutic BTX Procedures, by Country, Europe, 2007 - 2013
• Exhibit 12: Therapeutic BTX Procedures, Japan, 2007 - 2013
• Exhibit 13: Therapeutic BTX Market, by Country, Global (US$), 2007 - 2013 (Tabular Format)
• Exhibit 14: Therapeutic BTX Market, by Country, Global (€ , £, and ¥), 2007 - 2013 Exhibit 15: Drivers and Limiters of the Therapeutic BTX Market, Global
• Exhibit 16: Leading Competitors in the Therapeutic BTX Market, by Country, as % of Total, Global, 2008

CHAPTER 2: US THERAPEUTIC BOTULINUM TOXIN MARKET

• Exhibit 17: Therapeutic BTX Market, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 18: Therapeutic BTX Market, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 19: Therapeutic BTX Market Growth, US, 2008 - 2013
• Exhibit 20: Drivers and Limiters of the Therapeutic BTX Market, US
• Exhibit 21: Leading Competitors in the Therapeutic BTX Market, as a % of Total, US, 2008

CHAPTER 3: EUROPEAN THERAPEUTIC BOTULINUM TOXIN MARKET

• Exhibit 22: Therapeutic BTX Market, by Country, Europe (US$), 2007 - 2013 (Graphical Format)
• Exhibit 23: Therapeutic BTX Market, by Country, Europe (US$), 2007 - 2013 (Tabular Format)
• Exhibit 24: Therapeutic BTX Market, by Country, Europe (€ and £), 2007 - 2013
• Exhibit 25: Therapeutic BTX Market Growth, by Country, Europe, 2008 - 2013
• Exhibit 26: Drivers and Limiters of the Therapeutic BTX Market, Europe
• Exhibit 27: Leading Competitors in the Therapeutic BTX Market, by Country, as a % of Total, Europe, 2008

CHAPTER 4: JAPANESE THERAPEUTIC BOTULINUM TOXIN MARKET

• Exhibit 28: Therapeutic BTX Market, Japan (US$), 2007 - 2013
• Exhibit 29: Therapeutic BTX Market, Japan (US$ and ¥), 2007 - 2013
• Exhibit 30: Therapeutic BTX Market Growth, Japan, 2008 - 2013
• Exhibit 31: Drivers and Limiters of the Therapeutic BTX Market, Japan
• Exhibit 32: Leading Competitors in the Therapeutic BTX Market, as a % of Total, Japan, 2008

APPENDIX B: SUPPLEMENTAL EXHIBITS

• Exhibit 33: Therapeutic BTX Market, Global (US$), 2007 - 2013 (Detailed Format)
• Exhibit 34: Therapeutic BTX Market, by Indication, US, as a % of Total, 2008 and 2013 (Detailed Format)
• Exhibit 35: Therapeutic BTX Market Units, Europe, 2007 - 2013 (Detailed Format)
• Exhibit 36: Therapeutic BTX Market, Japan (US$), 2007 - 2013 (Detailed Format)